Nona Shayegi

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML

Nona Shayegi, Michael Krämer, Martin Bornhäuser et al. · Blood · 2013 · 193 citations

Medicine, Molecular Genetics, Oncology +13

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

Anke Theil, Sebastian Tuve, Uta Oelschlägel et al. · Cytotherapy · 2015 · 178 citations

Life Sciences, Immunology, Clinical Immunology +15

Monitoring of Hematopoietic Chimerism after Transplantation for Pediatric Myelodysplastic Syndrome: Real-Time or Conventional Short Tandem Repeat PCR in Peripheral Blood or Bone Marrow?

André Willasch, Hermann Kreyenberg, Nona Shayegi et al. · Biology of Blood and Marrow Transplantation · 2014 · 36 citations · Full text

Medicine, Hematology, Pediatrics +17

Sequence Polymorphism Systems for Quantitative Real-Time Polymerase Chain Reaction to Characterize Hematopoietic Chimerism—High Informativity and Sensitivity As Well As Excellent Reproducibility and Precision of Measurement

André Willasch, Gaby Schneider, Britta Sofia Reincke et al. · Laboratory Hematology · 2007 · 25 citations · Full text

Medicine, Genetics, Hematology +14

In Vivo Chemical Screen in Zebrafish Embryos Identifies Regulators of Hematopoiesis Using a Semiautomated Imaging Assay

Guruchandar Arulmozhivarman, Martin Stöter, Marc Bickle et al. · SLAS DISCOVERY · 2016 · 15 citations · Full text

Medicine, Hematology, Pharmacology +17